Literature DB >> 20676056

ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.

Peer-Hendrik Kuhn1, Huanhuan Wang, Bastian Dislich, Alessio Colombo, Ulrike Zeitschel, Joachim W Ellwart, Elisabeth Kremmer, Steffen Rossner, Stefan F Lichtenthaler.   

Abstract

The amyloid precursor protein (APP) undergoes constitutive shedding by a protease activity called alpha-secretase. This is considered an important mechanism preventing the generation of the Alzheimer's disease amyloid-beta peptide (Abeta). alpha-Secretase appears to be a metalloprotease of the ADAM family, but its identity remains to be established. Using a novel alpha-secretase-cleavage site-specific antibody, we found that RNAi-mediated knockdown of ADAM10, but surprisingly not of ADAM9 or 17, completely suppressed APP alpha-secretase cleavage in different cell lines and in primary murine neurons. Other proteases were not able to compensate for this loss of alpha-cleavage. This finding was further confirmed by mass-spectrometric detection of APP-cleavage fragments. Surprisingly, in different cell lines, the reduction of alpha-secretase cleavage was not paralleled by a corresponding increase in the Abeta-generating beta-secretase cleavage, revealing that both proteases do not always compete for APP as a substrate. Instead, our data suggest a novel pathway for APP processing, in which ADAM10 can partially compete with gamma-secretase for the cleavage of a C-terminal APP fragment generated by beta-secretase. We conclude that ADAM10 is the physiologically relevant, constitutive alpha-secretase of APP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676056      PMCID: PMC2944055          DOI: 10.1038/emboj.2010.167

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Control of peripheral nerve myelination by the beta-secretase BACE1.

Authors:  Michael Willem; Alistair N Garratt; Bozidar Novak; Martin Citron; Steve Kaufmann; Andrea Rittger; Bart DeStrooper; Paul Saftig; Carmen Birchmeier; Christian Haass
Journal:  Science       Date:  2006-09-21       Impact factor: 47.728

2.  ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.

Authors:  Gisela Weskamp; Jill W Ford; Jamie Sturgill; Steve Martin; Andrew J P Docherty; Steven Swendeman; Neil Broadway; Dieter Hartmann; Paul Saftig; Shelby Umland; Atsuko Sehara-Fujisawa; Roy A Black; Andreas Ludwig; J David Becherer; Daniel H Conrad; Carl P Blobel
Journal:  Nat Immunol       Date:  2006-10-29       Impact factor: 25.606

3.  A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein.

Authors:  Susanne Schöbel; Stephanie Neumann; Maren Hertweck; Bastian Dislich; Peer-Hendrik Kuhn; Elisabeth Kremmer; Brian Seed; Ralf Baumeister; Christian Haass; Stefan F Lichtenthaler
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

4.  Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope.

Authors:  Luke A Miles; Kwok S Wun; Gabriela A N Crespi; Michelle T Fodero-Tavoletti; Denise Galatis; Christopher J Bagley; Konrad Beyreuther; Colin L Masters; Roberto Cappai; William J McKinstry; Kevin J Barnham; Michael W Parker
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

5.  Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein.

Authors:  Stephanie Neumann; Susanne Schöbel; Sebastian Jäger; Anna Trautwein; Christian Haass; Claus U Pietrzik; Stefan F Lichtenthaler
Journal:  J Biol Chem       Date:  2005-12-12       Impact factor: 5.157

6.  P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing.

Authors:  Jean M Camden; Ann M Schrader; Ryan E Camden; Fernando A González; Laurie Erb; Cheikh I Seye; Gary A Weisman
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

7.  Expression cloning screen for modifiers of amyloid precursor protein shedding.

Authors:  Susanne Schöbel; Stephanie Neumann; Brian Seed; Stefan F Lichtenthaler
Journal:  Int J Dev Neurosci       Date:  2006-01-30       Impact factor: 2.457

8.  Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.

Authors:  Richard M Page; Karlheinz Baumann; Masanori Tomioka; Blanca I Pérez-Revuelta; Akio Fukumori; Helmut Jacobsen; Alexander Flohr; Thomas Luebbers; Laurence Ozmen; Harald Steiner; Christian Haass
Journal:  J Biol Chem       Date:  2007-10-24       Impact factor: 5.157

Review 9.  Alpha-secretase as a therapeutic target.

Authors:  Falk Fahrenholz
Journal:  Curr Alzheimer Res       Date:  2007-09       Impact factor: 3.498

Review 10.  Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.

Authors:  S Bandyopadhyay; L E Goldstein; D K Lahiri; J T Rogers
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  245 in total

Review 1.  Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin.

Authors:  Johannes Prox; Andrea Rittger; Paul Saftig
Journal:  Exp Brain Res       Date:  2011-11-27       Impact factor: 1.972

2.  Translational repression of the disintegrin and metalloprotease ADAM10 by a stable G-quadruplex secondary structure in its 5'-untranslated region.

Authors:  Sven Lammich; Frits Kamp; Judith Wagner; Brigitte Nuscher; Sonja Zilow; Ann-Katrin Ludwig; Michael Willem; Christian Haass
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

Review 3.  Regulation of α-secretase ADAM10 expression and activity.

Authors:  Kristina Endres; Falk Fahrenholz
Journal:  Exp Brain Res       Date:  2011-10-04       Impact factor: 1.972

Review 4.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.

Authors:  Silke Brunholz; Sangram Sisodia; Alfredo Lorenzo; Carole Deyts; Stefan Kins; Gerardo Morfini
Journal:  Exp Brain Res       Date:  2011-09-30       Impact factor: 1.972

5.  ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.

Authors:  Marcia L Moss; Gary Powell; Miles A Miller; Lori Edwards; Bin Qi; Qing-Xiang Amy Sang; Bart De Strooper; Ina Tesseur; Stefan F Lichtenthaler; Mara Taverna; Julia Li Zhong; Colin Dingwall; Taheera Ferdous; Uwe Schlomann; Pei Zhou; Linda G Griffith; Douglas A Lauffenburger; Robert Petrovich; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

6.  Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons.

Authors:  Peer-Hendrik Kuhn; Katarzyna Koroniak; Sebastian Hogl; Alessio Colombo; Ulrike Zeitschel; Michael Willem; Christiane Volbracht; Ute Schepers; Axel Imhof; Albrecht Hoffmeister; Christian Haass; Steffen Roßner; Stefan Bräse; Stefan F Lichtenthaler
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

7.  Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Authors:  Qiying Sun; Harald Hampel; Kaj Blennow; Simone Lista; Allan Levey; Beisha Tang; Rena Li; Yong Shen
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway.

Authors:  Kotaro Furusawa; Toshiyuki Takasugi; Yung-Wen Chiu; Yukiko Hori; Taisuke Tomita; Mitsunori Fukuda; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

Review 9.  Targeting the β secretase BACE1 for Alzheimer's disease therapy.

Authors:  Riqiang Yan; Robert Vassar
Journal:  Lancet Neurol       Date:  2014-02-17       Impact factor: 44.182

10.  Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases.

Authors:  Magdalena Nutu; Philippe Bourgeois; Henrik Zetterberg; Erik Portelius; Ulf Andreasson; Stéphane Parent; Francesco Lipari; Sara Hall; Radu Constantinescu; Oskar Hansson; Kaj Blennow
Journal:  Neuromolecular Med       Date:  2012-12-07       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.